AI Model MANAS-1 Detects Mental Health Disorders via...
Indian researchers have developed an AI model, MANAS-1, that analyzes brain waves to identify neurological and psychiatric disorders, promising faster diagnoses.
Introduction
Indian researchers have developed an innovative AI system named MANAS-1 that interprets brain waves to identify neurological and psychiatric disorders. This model utilizes standard electroencephalogram (EEG) equipment to analyze electrical signals from the brain.
How MANAS-1 Works
The MANAS-1 model processes brain wave data as a structured language that artificial intelligence can learn to interpret. According to Dr. Puneet Agarwal, the neurologist behind this technology and a professor at Max Super Speciality Hospital in New Delhi, the system was trained on an extensive dataset comprising 60,000 hours of brain wave data from over 25,000 patients globally.
EEG Technology
MANAS-1 employs EEG technology to capture the electrical activity of the brain. The AI analyzes these brain wave patterns to identify distinct signatures associated with various neurological and psychiatric conditions. Currently, the system operates with 400 million parameters—variables it utilizes to make decisions based on training data. Plans are in place to expand this to 2 billion parameters to enhance accuracy, with a second version, MANAS-2, expected to be released in the coming weeks.
Dr. Agarwal emphasizes that the model can interpret the connections and communications between different brain regions, enhancing its diagnostic capabilities.
Importance of the Technology
This technology has the potential to provide faster and more cost-effective diagnoses of brain disorders. Traditional neurological testing often requires expensive equipment and specialist interpretation, whereas MANAS-1 can function with standard EEG machines commonly found in hospitals.
Dr. Agarwal reports that the model achieves an impressive 95% accuracy in identifying computational markers for epilepsy and mental health disorders. If validated independently, this could significantly improve access to brain health screenings in areas with a shortage of specialist doctors.
Broader Applications
Beyond diagnosis, the MANAS-1 system holds promise for applications in cognitive assessment and the development of brain-computer interfaces. Such interfaces could enable paralyzed patients to control devices using their thoughts, showcasing the model's versatility.
Context in AI Development
MANAS-1 is part of a growing field of AI tools designed to analyze brain activity. For instance, researchers in Singapore developed Brain-JEPA, which also identifies brain regions and their functions to assist in diagnosing disorders and predicting disease progression. Additionally, South Korean scientists have created an AI model capable of predicting dementia risk based on voice recordings from elderly patients.
In India, Google has been actively supporting healthcare AI development, partnering with institutions like the All India Institute of Medical Sciences and the Indian Institute of Science to create AI tools for diagnosing skin conditions and sorting hospital patients. Earlier this year, Google also released MedGemma 1.5, an open-source medical AI model in India.
Conclusion
The development of the MANAS-1 AI model represents a significant advancement in the field of mental health diagnostics, potentially transforming how brain disorders are identified and treated.
Source: Indian AI model reads brain waves to spot mental health disorders - DHArab
Source:
Related News
UAE Hospital Pioneers Fetal Keyhole Surgery for Spina Bifida
Danat Al Emarat Hospital in Abu Dhabi becomes the first facility in the Middle East to perform minimally invasive keyhole surgery on unborn babies to treat spina bifida. The groundbreaking procedure offers hope for families facing this serious birth defect.
India Launches Mobile App for Community Health Officers
India's Ministry of Health has unveiled a mobile application developed by ICMR to support community health officers with clinical decision-making and streamlined workflows. The app features color-coded systems and integrates with national digital health platforms.
J&J Launches Free Cancer Testing Program in UAE
Johnson & Johnson has introduced a comprehensive program in the UAE providing free liquid biopsy testing for advanced lung cancer patients whose insurance doesn't cover genetic testing. The initiative targets metastatic non-small cell lung cancer cases.
Ready to Transform Your Clinic?
Join hundreds of healthcare providers who trust daoini for their practice management
